• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
67.40
  -0.53  
- 0.78%
443,626,000
68.91
28.09

Insider Trade Data

Date Insider Shares Type Value
04/14/2015 Moy, Jeffrey C 20,766 Sell $1,383,560
03/25/2015 Balo, Andrew K 7,500 Sell $457,849
03/25/2015 Balo, Andrew K 7,500 Exchange $73,500
03/23/2015 Doubleday, Richard B 4,000 Sell $244,992
03/23/2015 Doubleday, Richard B 4,000 Exchange $24,120

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!